Variant report

Variant	nsv610264
Chromosome Location	chr8:10158428-10181176
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:136)
CpG islands
(count:0)
Chromatin interactive
region (count:4)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:136 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BATF	chr8:10176676-10176929	GM12878	blood:	n/a	n/a
2	BHLHE40	chr8:10171432-10171448	GM12878	blood:	n/a	n/a
3	CEBPB	chr8:10176884-10177088	HepG2	liver:	n/a	n/a
4	CEBPB	chr8:10164442-10164502	HepG2	liver:	n/a	chr8:10164448-10164459
5	CEBPB	chr8:10159793-10160252	HepG2	liver:	n/a	chr8:10159798-10159811
6	CTCF	chr8:10174400-10174550	GM12868	blood:	n/a	n/a
7	CTCF	chr8:10174406-10174548	MCF-7	breast:	n/a	n/a
8	CTCF	chr8:10174340-10174490	AG04449	skin:	n/a	n/a
9	CTCF	chr8:10174420-10174570	GM12864	blood:	n/a	n/a
10	CTCF	chr8:10174100-10174250	GM12875	blood:	n/a	n/a
11	CTCF	chr8:10178920-10178960	K562	blood:	n/a	n/a
12	CTCF	chr8:10174380-10174530	A549	lung:	n/a	n/a
13	CTCF	chr8:10174400-10174550	BE2_C	brain:	n/a	n/a
14	CTCF	chr8:10174280-10174430	HFF-Myc	foreskin:	n/a	n/a
15	CTCF	chr8:10174420-10174570	BE2_C	brain:	n/a	n/a
16	CTCF	chr8:10174400-10174550	GM12878	blood:	n/a	n/a
17	CTCF	chr8:10174380-10174530	NHEK	skin:	n/a	n/a
18	CTCF	chr8:10174460-10174610	GM12865	blood:	n/a	n/a
19	CTCF	chr8:10174380-10174530	GM12864	blood:	n/a	n/a
20	CTCF	chr8:10174380-10174530	RPTEC	kidney:	n/a	n/a
21	CTCF	chr8:10174420-10174570	HCT-116	colon:	n/a	n/a
22	CTCF	chr8:10174340-10174490	GM12878	blood:	n/a	n/a
23	CTCF	chr8:10174400-10174550	AG04450	lung:	n/a	n/a
24	CTCF	chr8:10174400-10174550	GM12874	blood:	n/a	n/a
25	CTCF	chr8:10174440-10174534	NHEK	skin:	n/a	n/a
26	CTCF	chr8:10174359-10174543	HepG2	liver:	n/a	n/a
27	CTCF	chr8:10174380-10174530	GM12873	blood:	n/a	n/a
28	CTCF	chr8:10174380-10174530	GM12865	blood:	n/a	n/a
29	CTCF	chr8:10174360-10174510	GM12864	blood:	n/a	n/a
30	CTCF	chr8:10174280-10174430	MCF-7	breast:	n/a	n/a
31	CTCF	chr8:10174394-10174535	GM12878	blood:	n/a	n/a
32	CTCF	chr8:10174400-10174550	HRPEpiC	eye:	n/a	n/a
33	CTCF	chr8:10174380-10174530	GM12872	blood:	n/a	n/a
34	CTCF	chr8:10174476-10174506	Kidney_OC	kidney:	n/a	n/a
35	CTCF	chr8:10174400-10174550	Caco-2	colon:	n/a	n/a
36	CTCF	chr8:10174340-10174490	HAc	cerebellar:	n/a	n/a
37	CTCF	chr8:10174400-10174550	K562	blood:	n/a	n/a
38	CTCF	chr8:10174240-10174390	NHEK	skin:	n/a	n/a
39	CTCF	chr8:10178893-10179000	H1-hESC	embryonic stem cell:	n/a	n/a
40	CTCF	chr8:10174420-10174570	GM12869	blood:	n/a	n/a
41	CTCF	chr8:10174300-10174450	RPTEC	kidney:	n/a	n/a
42	CTCF	chr8:10174200-10174350	HBMEC	blood vessel:	n/a	n/a
43	CTCF	chr8:10174400-10174550	HPF	lung:	n/a	n/a
44	CTCF	chr8:10174380-10174530	AG04450	lung:	n/a	n/a
45	CTCF	chr8:10174219-10174646	H1-hESC	embryonic stem cell:	n/a	n/a
46	CTCF	chr8:10174400-10174550	HRE	kidney:	n/a	n/a
47	CTCF	chr8:10174400-10174550	GM12871	blood:	n/a	n/a
48	CTCF	chr8:10174400-10174550	GM12873	blood:	n/a	n/a
49	CTCF	chr8:10174420-10174570	MCF-7	breast:	n/a	n/a
50	CTCF	chr8:10174360-10174510	Hela-S3	cervix:	n/a	n/a

No data

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr8:10174620..10177509-chr8:10182842..10184423,2	K562	blood:
2	chr8:10169157..10171450-chr8:10182370..10185082,2	MCF-7	breast:
3	chr2:112640154..112641899-chr8:10166576..10168096,3	MCF-7	breast:
4	chr8:10178281..10180046-chr8:10185118..10187450,2	K562	blood:

No data

Variant related genes	Relation type
MSRA	TF binding region
ENSG00000175806	chromatin interactions
ENSG00000153107	chromatin interactions

Extended variants
information (count: 1275 )
Associated
traits (count: 136 )

Variant overlapped rSNPs/rCNVs (count:1275 , 50 per page) page: 1 2 3 4 5 6 7 ... 26

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7822305	chr8:10158428-10158429	Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs547660493	chr8:10158429-10158430	Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs566315864	chr8:10158432-10158433	Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs535205356	chr8:10158436-10158437	Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs558194125	chr8:10158480-10158481	Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs183221325	chr8:10158491-10158492	Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs149359515	chr8:10158517-10158518	Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs4240640	chr8:10158521-10158522	Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs150593531	chr8:10158539-10158540	Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs189691515	chr8:10158563-10158564	Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs542762141	chr8:10158613-10158614	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs182348112	chr8:10158624-10158625	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs572990131	chr8:10158650-10158651	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs545168560	chr8:10158686-10158687	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs564894085	chr8:10158687-10158688	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs140637851	chr8:10158692-10158693	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs551845343	chr8:10158706-10158707	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs544469122	chr8:10158716-10158717	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs560909877	chr8:10158732-10158733	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs187785070	chr8:10158753-10158754	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs546750214	chr8:10158767-10158768	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs73193550	chr8:10158769-10158770	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs532079977	chr8:10158790-10158791	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs551967385	chr8:10158813-10158814	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs571708828	chr8:10158831-10158832	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs111427921	chr8:10158851-10158852	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs191169129	chr8:10158854-10158855	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs550859719	chr8:10158885-10158886	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs76468476	chr8:10158896-10158897	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs370372546	chr8:10158898-10158899	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs536231334	chr8:10158933-10158934	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs553082119	chr8:10158959-10158960	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs573299726	chr8:10158965-10158966	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs148500622	chr8:10158966-10158967	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs369871555	chr8:10159019-10159020	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs538714201	chr8:10159020-10159021	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs371830626	chr8:10159026-10159027	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs199668432	chr8:10159027-10159028	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs575340906	chr8:10159032-10159033	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs113635884	chr8:10159033-10159034	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs370958638	chr8:10159037-10159038	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs373125212	chr8:10159041-10159042	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs376060299	chr8:10159061-10159062	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs561150329	chr8:10159066-10159067	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs183626962	chr8:10159071-10159072	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs370239799	chr8:10159081-10159082	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs375349953	chr8:10159114-10159115	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs201317093	chr8:10159126-10159127	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs367978405	chr8:10159135-10159136	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs371090925	chr8:10159136-10159137	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:136)

Disease	PMID	Source
Crohn''s disease	19220326	CNVD
Psoriasis	19220326	CNVD
Prostate cancer	21965145	CNVD
Prostate cancer	18515986	CNVD
Chronic obstructive pulmonary disease	20378733	CNVD
Autism	18414403	CNVD
Cancer	21183584	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Breast cancer	17603634	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Ovarian cancer	20844748	CNVD
Cervical cancer	17311676	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Schizophrenia	20877625	CNVD
Disorders of sex development	21048976	CNVD
Colorectal cancer	16272173	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Breast cancer	17001317	CNVD
Thyroid cancer	19087340	CNVD
Multiple myeloma	16616336	CNVD
Hepatocellular carcinoma	22174799	CNVD
Heart disease	21282601	CNVD
Prostate cancer	16573809	CNVD
T-cell lymphomas	19863542	CNVD
Ovarian cancer	22174824	CNVD
Colorectal cancer	21297112	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Salivary gland tumor	18059337	CNVD
Breast cancer	17133270	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Breast cancer	17393978	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Breast cancer	20837533	CNVD
Squamous cell cancer	21044232	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	22429812	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Colorectal cancer	20709793	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Basal cell lymphoma	21115979	CNVD
Breast cancer	21264507	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Prostate cancer	21088497	CNVD
Breast cancer	20940404	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Gastric cancer	17167181	CNVD
Prostate cancer	16705090	CNVD
8p-syndrome	17576883	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	16968546	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Prostate cancer	17245344	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Cancer	16751803	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Autism	19415332	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Esophageal cancer	21851588	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21245420	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Breast cancer	21785460	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21509527	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Acute myeloid leukemia	21251322	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
lymphocytic leukemia	21291569	CNVD
Liver carcinoma	19366792	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Congenital diaphragmatic hernia	21064195	CNVD
Autism	22495311	CNVD
Myelofibrosis	22110671	CNVD
Intellectual disability	22045946	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Breast cancer	16608533	CNVD
Seminomas	18059402	CNVD
Lung cancer	18438408	CNVD
Lung squamous cell carcinoma	22363434	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Breast cancer	21990379	CNVD
Psoriasis	20403174	CNVD
Psoriasis	20663923	CNVD
Crohn''s disease	16909382	CNVD
Cancer	21129771	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Crohn''s disease	20877625	CNVD
Inflammatory disorder	20877625	CNVD
Cardiac defect	21933911	CNVD
Psoriasis	18059266	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Psoriasis	20877625	CNVD
Mental retardation	17847001	CNVD
Prostate cancer	17217626	CNVD
Schizophrenia	21399695	CNVD
Colorectal cancer	21128281	CNVD
Colorectal cancer	19455253	CNVD
Psoriasis	18848619	CNVD
Squamous cell cancer	19047905	CNVD
Colorectal cancer	17229543	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Myxofibrosarcoma	16751306	CNVD
Immune disease	21572526	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Kallmann Syndrome 2	22470819	CNVD
Developmental disorder	20461109	CNVD
abnormal development	18461090	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Glioblastoma multiforme	21138945	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21364760	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:269 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:10144400-10167000	Weak transcription	Right Ventricle	heart
2	chr8:10148200-10159800	Weak transcription	Primary neutrophils fromperipheralblood	blood
3	chr8:10149400-10163400	Weak transcription	Cortex derived primary cultured neurospheres	brain
4	chr8:10151000-10160000	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
5	chr8:10151400-10177000	Weak transcription	Fetal Intestine Small	intestine
6	chr8:10151400-10178800	Weak transcription	Spleen	Spleen
7	chr8:10153400-10167000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
8	chr8:10154400-10163200	Weak transcription	Esophagus	oesophagus
9	chr8:10155000-10159000	Weak transcription	Fetal Muscle Leg	muscle
10	chr8:10157200-10177600	Weak transcription	Stomach Smooth Muscle	stomach
11	chr8:10157400-10161000	Enhancers	Fetal Brain Male	brain
12	chr8:10158000-10177400	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
13	chr8:10158200-10159200	Enhancers	H1 Cell Line	embryonic stem cell
14	chr8:10158200-10159400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
15	chr8:10158200-10159400	Enhancers	iPS-18 Cell Line	embryonic stem cell
16	chr8:10158200-10159400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
17	chr8:10158200-10160200	Enhancers	Fetal Brain Female	brain
18	chr8:10158200-10161000	Enhancers	Brain Germinal Matrix	brain
19	chr8:10158200-10163400	Weak transcription	Primary T cells from cord blood	blood
20	chr8:10158400-10158600	Enhancers	iPS-20b Cell Line	embryonic stem cell
21	chr8:10158400-10158600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
22	chr8:10158400-10158600	Enhancers	Brain Anterior Caudate	brain
23	chr8:10158400-10158800	Enhancers	iPS-15b Cell Line	embryonic stem cell
24	chr8:10158400-10159000	Enhancers	HUES48 Cell Line	embryonic stem cell
25	chr8:10158400-10159000	Enhancers	HUES6 Cell Line	embryonic stem cell
26	chr8:10158400-10159200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
27	chr8:10158400-10159200	Enhancers	H9 Cell Line	embryonic stem cell
28	chr8:10158400-10159400	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
29	chr8:10158400-10159600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
30	chr8:10158600-10159000	Enhancers	ES-I3 Cell Line	embryonic stem cell
31	chr8:10158600-10159000	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
32	chr8:10158600-10159200	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
33	chr8:10158600-10159200	Enhancers	HUES64 Cell Line	embryonic stem cell
34	chr8:10158600-10159600	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
35	chr8:10158600-10166800	Weak transcription	Lung	lung
36	chr8:10158600-10178200	Weak transcription	Brain Anterior Caudate	brain
37	chr8:10158800-10177600	Weak transcription	Primary B cells from cord blood	blood
38	chr8:10159000-10159400	Enhancers	Fetal Muscle Leg	muscle
39	chr8:10159000-10160200	Weak transcription	Aorta	Aorta
40	chr8:10159000-10177400	Weak transcription	Monocytes-CD14+_RO01746	blood
41	chr8:10159200-10170600	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
42	chr8:10159600-10161400	Strong transcription	Ganglion Eminence derived primary cultured neurospheres	brain
43	chr8:10159800-10160600	Enhancers	Liver	Liver
44	chr8:10159800-10161800	Strong transcription	Primary neutrophils fromperipheralblood	blood
45	chr8:10160000-10160400	Enhancers	Pancreas	Pancrea
46	chr8:10160000-10160600	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
47	chr8:10160000-10161200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
48	chr8:10160200-10160600	ZNF genes & repeats	Aorta	Aorta
49	chr8:10160200-10160600	Enhancers	Brain Angular Gyrus	brain
50	chr8:10160200-10170400	Weak transcription	Fetal Brain Female	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links